Power morcellators are surgical rotating blade devices used for grinding uterine fibroids into tiny fragments. The fragments can then be suctioned out from the abdomen through a small incision. Unfortunately, the design of the previously FDA-approved morcellator often leaves tiny fragments of tissue behind, which might be cancerous and easily spread. In addition, many doctors have been negligent in their actions by not determining if the uterine fibroids are cancerous before using the device.A Failure to Warn Patients About Dangers
The FDA (Food & Drug Administration) has warned women, doctors and medical device manufacturers that power morcellators may be spreading cancer that was previously undetected. This issued warning is leading to numerous investigations of women with diagnosed leiomyosarcoma, who have had their uterine fibroids removed by a doctor using a power morcellator.
Since the 1990s, hundreds of thousands of women have had fibroid tumor removal and hysterectomies each year. In fact, many hysterectomies are performed as a way to treat uterine fibroids. The FDA believes that leiomyosarcoma, a rare deadly cancer, may be spread throughout a woman’s abdominal cavity as a result of fibroid tumor removal or hysterectomies from procedures using a power morcellator.
Rosenfeld Injury Lawyers is committed to helping women with leiomyosarcoma and other forms of cancer following a morcellator procedure get the compensation they are entitled to for their medical care and non-economic expenses. We invite you to contact our office for a free case evaluation and frank discussion of your legal rights. We are also available to discuss the status of lawsuits involving power morcellators.
Many doctors and medical device manufacturers are failing to warn patients of the high level of risk involved in morcellators used to perform uterine fibroid removal and hysterectomies. Many hospitals across the United States have stopped using the medical device since long before the FDA warning.
• Blue Endo
• Lumenis Inc.
• Interlace Medical
• LiNA Medical
• Richard Wolf
• Smith & Nephew
In April 2014, the Food & Drug Administration announced an advisory panel would soon convene, investigating the correlation between the spread of uterine cancer and the use of a power morcellator. The agency continues to discourage morcellation as a procedure for fibroid removal or hysterectomies. As a result, Johnson & Johnson has temporarily suspended any sales of its morcellator device until it receives further guidance from the FDA.
Presently, there are no FDA recalls of this device.
• Robotic Hysterectomy
• Laparoscopic Supercervical Hysterectomy
• Hospital costs
• Lost wages
• Lifestyle stress
• Wrongful death